Related Experiment Video

Updated: Apr 25, 2026

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
07:32

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Published on: September 30, 2019

7.4K

Bacteriophages displaying anticancer peptides in combined antibacterial and anticancer treatment

Krystyna Dąbrowska1, Zuzanna Kaźmierczak, Joanna Majewska

  • 1Institute of Immunology & Experimental Therapy, Polish Academy of Sciences, Weigla 12, 53-114 Wrocław, Poland.

Future Microbiology
|August 27, 2014
PubMed
Abstract

Insights

Engineered bacteriophages carrying anticancer peptides demonstrated reduced tumor growth and improved wound healing in mice. This dual-action therapy leverages natural antibacterial properties with targeted anticancer effects for novel treatments.

Area of Science:

  • Biotechnology
  • Oncology
  • Microbiology

Background:

  • Bacteriophages (phages) are explored as drug carriers for cancer therapy.
  • Phages possess inherent antibacterial activity, posing a challenge for solely anticancer applications.
  • Combining engineered anticancer functions with natural antibacterial properties is a novel therapeutic approach.

Purpose of the Study:

  • To assess the combined anticancer and antibacterial activity of engineered bacteriophages.
  • To evaluate the efficacy of bacteriophages displaying anticancer peptides in a tumor model with wound infection.

Main Methods:

  • Utilized a BALB/c mouse model with 4T1 tumor growth and surgical wound infection.
  • Modified T4 bacteriophages with Tyr-Ile-Gly-Ser-Arg (YIGSR) peptides via phage display.
  • Administered YIGSR-displaying phages intraperitoneally.

Main Results:

  • Significant decrease in tumor growth observed in mice treated with YIGSR-displaying phages.
  • Marked reduction in wound severity, bacterial load, and inflammatory markers.
  • Demonstrated synergistic therapeutic effects of engineered and natural phage activities.

Conclusions:

  • Engineered bacteriophages effectively combine anticancer and antibacterial functions.
  • This dual-action phage therapy shows promise for treating complex conditions involving tumors and infections.
  • Further research into bacteriophage-based dual-action therapies is warranted.
Keywords:
T4 phageantibacterialanticancerinfectionphage displaywound

More Related Videos

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings07:22

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Published on: August 19, 2021

3.1K
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

11.8K

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
60.0K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K